VEA Stock Recent News

ETFs had a standout year in 2024, seeing over $1 trillion in flows for the first year in history. Total ETF assets under management grew to an impressive $10.4 trillion by year end thanks to strong flows and price appreciation.

In December, we welcomed 29 new analysts to Seeking Alpha and in this article we are showcasing their stock picks and investment strategies. Five buy picks are highlighted on Viasat, Newmont, NeuroOne Medical, X-Fab Silicon Foundries, and ArcerlorMittal. Analysts' recommendations range from Strong Buy to Strong Sell, covering diverse sectors such as healthcare, technology, energy, and consumer goods.

Exclude China and broadly defined EM stocks are posting substantially softer results, based on a set of ETFs through Friday's close. US shares are effectively neck and next with EM so far in 2024.

I maintain a buy rating on VEA due to its attractive valuation, strong diversification, and higher dividend yield compared to US equities. VEA's underperformance relative to the S&P 500 is due to its lower exposure to tech and higher exposure to cyclical sectors. The US Dollar Index's stability in 2024 has been a tailwind, but VEA's diversified holdings have limited its alpha generation.

On this episode of the “ETF of the Week” podcast, VettaFi's Head of Research Todd Rosenbluth discussed the Franklin FTSE United Kingdom ETF (FLGB) with Chuck Jaffe of “Money Life.” The pair talked about several topics regarding the fund to give investors a deeper understanding of the ETF overall.

VEA is a buy due to solid outlook for developed markets including Japan, its low expense ratio, high diversification, and substantial dividend yield. VEA excludes emerging markets and therefore reduces risks associated with Chinese holdings including tariffs and investment bans. VEA offers investors with diversification away from U.S. markets which currently have multiple indicators of being overvalued.

Hello! This is MarketWatch reporter Isabel Wang bringing you this week's ETF Wrap. In this edition, we look at Europe exchange-traded funds on the back of the first interest-rate cut by the European Central Bank since 2019. Investors are fretting over whether there's room for these regional equities to build on their record-hitting rally so far this year.

LVHI: Well-Rounded Product, But Looks Overextended For Now

Vanguard FTSE Developed Markets ETF has underperformed the S&P 500 but has shown modest alpha since mid-February. VEA has a compelling valuation and some foreign-developed stock markets are reaching all-time highs. VEA's low PEG ratio, high dividend yield, diversified allocation across sectors, and improved chart are positive factors.

ICOW: Attractive Fundamentals, Average Performance